Peigang Yang
Hebei Medical University(CN)Hebei University of Economics and Business(CN)Union Hospital(CN)Central South University(CN)Third Hospital of Hebei Medical University(CN)Center for Agricultural Resources Research(CN)Fourth Hospital of Hebei Medical University(CN)Hunan Cancer Hospital(CN)Hebei Food Inspection and Research Institute(CN)Huazhong University of Science and Technology(CN)Yangzhou University(CN)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment, Metastasis and carcinoma case studies, Nutrition and Health in Aging, Esophageal Cancer Research and Treatment
Most-Cited Works
- → Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study(2022)159 cited
- → HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a(2015)59 cited
- → Sarcopenia: Molecular regulatory network for loss of muscle mass and function(2023)49 cited
- → Efficacy and safety of sintilimab plus XELOX as a neoadjuvant regimen in patients with locally advanced gastric cancer: A single-arm, open-label, phase II trial(2022)46 cited
- → Phase angle derived from bioelectrical impedance analysis as a marker for predicting sarcopenia(2022)44 cited
- → Predictive Effect of Systemic Immune-Inflammation Index Combined With Prognostic Nutrition Index Score on Efficacy and Prognosis of Neoadjuvant Intraperitoneal and Systemic Paclitaxel Combined With Apatinib Conversion Therapy in Gastric Cancer Patients With Positive Peritoneal Lavage Cytology: A Prospective Study